Birol Güvenç
Birol Güvenç publishes mostly in Hematology, Genetics and Oncology, on topics such as Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research and Chronic Myeloid Leukemia Treatments.
- World rank
- #7,681,508 of 7,710,434 ranked researchers
- Rank in Türkiye
- #116,726 of 117,622
- Works
- 198
- Citations
- 732
- Citations per work
- 3.7
What does Birol Güvenç research?
Birol Güvenç's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10854.7%
- Medicine10854.7%
- Everything else8040.4%
- Life Sciences104.9%
- 1Hematology24% of their works
- 2Genetics17% of their works
- 3Oncology5% of their works
- 4Molecular Biology5% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Hemoglobinopathies and Related Disorders
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Lymphoma Diagnosis and Treatment
Which keywords describe Birol Güvenç's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Minimal Residual Disease, Sickle-cell Disease, Thalassemia, Acute Myeloid Leukemia, AML and BCR-ABL.
- International Myeloma Working Group
- Classification
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- BCR-ABL
- AML
- Sickle-cell Disease
- Rituximab
- Prognostic Factors
- Minimal Residual Disease
- Thalassemia
- Acute Myeloid Leukemia
- Imatinib
- Myelofibrosis
- Genomic Aberrations
- Childhood Cancer
- Diagnosis Criteria
- Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors773 topics
- Rituximab412 topics
- Minimal Residual Disease382 topics
- Sickle-cell Disease361 topic
- Thalassemia361 topic
- AML321 topic
- Acute Myeloid Leukemia321 topic
- BCR-ABL321 topic
- Imatinib321 topic
- JAK2 Mutation251 topic
- Myelofibrosis251 topic
- Chronic Lymphocytic Leukemia241 topic
- Genomic Aberrations241 topic
- Acute Lymphoblastic Leukemia211 topic
- Childhood Cancer211 topic
- Classification171 topic
- Diagnosis Criteria171 topic
- International Myeloma Working Group171 topic
- Lymphoma171 topic
Where does Birol Güvenç work?
Birol Güvenç's main affiliation in the publication record is Cukurova University, Türkiye.
How many publications and citations does Birol Güvenç have?
OpenAlex counts 198 works and 732 citations for Birol Güvenç, an h-index of 17, ranking #7,681,508 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Birol Güvenç
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Birol Güvenç. Posts are plain text and can be reported.